Why the study?
The prognostic role of atrial fibrillation and its association with mortality in patients with transthyretin amyloid cardiomyopathy were not well established.
Does atrial fibrillation predict all-cause mortality in patients with transthyretin amyloid cardiomyopathy?
Does atrial fibrillation predict all-cause mortality in patients with transthyretin amyloid cardiomyopathy?
Answers are grounded in this paper and cite their sources.
In patients with ATTR-CM, atrial fibrillation is a marker of more advanced disease severity rather than an independent predictor of all-cause mortality.
Background and objective Atrial fibrillation (AF) is the most common arrhythmia in patients with transthyretin amyloid cardiomyopathy (ATTR-CM), although its prognostic role remains uncertain. There is substantial evidence regarding mortality when AF coexists with heart failure (HF). However, this association is not well established in patients with ATTR-CM. This study aimed to assess whether AF was an independent predictor of all-cause mortality in ATTR-CM. Methods A total of 22 patients with confirmed ATTR-CM were followed (mean follow-up: 18.2 ± 6.8 months). The association between AF and all-cause mortality was evaluated using Cox proportional hazards modeling. Results The cohort had a mean age of 72 years (AF: 75.0 ± 5.5 years vs. no AF: 69.0 ± 8.7 years), and 81.8% of patients were men. Nine (41%) patients died during follow-up; among these, six (67%) had AF. AF was present in 11 (50%) of patients. AF was associated with more advanced disease, including a higher proportion of ATTR stage III (45.5% vs. 18.2%; p = 0.14) and New York Heart Association (NYHA) class III-IV symptoms (81.8% vs. 54.5%; p = 0.13). AF was not associated with all-cause mortality in the unadjusted analysis (hazard ratio (HR) 2.12; 95% confidence interval (CI): 0.53-8.52) or after adjustment for age, ATTR stage III vs. I-II, and left ventricular global longitudinal strain (LVGLS) > -15% (HR: 0.90; 95% CI: 0.12-6.98). In contrast, ATTR stage III vs. I-II remained an independent predictor of mortality (HR: 7.05; 95% CI: 1.55-31.98). Conclusions Patients with ATTR-CM carry a high mortality burden. AF is a common rhythm disorder in this population and appears to represent a more advanced disease phenotype rather than an independent predictor of all-cause mortality. These findings suggest that AF may function as a marker of disease progression and a valuable element for clinical stratification.
No takes yet. Share an insight, caveat, or question.
Penate et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: